.
MergerLinks Header Logo

New Deal

New Deal

Cover Image Ludwig N. Hantson
Ludwig N. HantsonALEXION PHARMACEUTICALS INC

Ludwig N. Hantson

CEO at ALEXION PHARMACEUTICALS INC

Manager

Deal Bio

Total Deals4
Valued Deals4
Total Value£32,554M
Avg. Deal Size£8,138M

Expertise (4)

Key Relationships

United States
Biotechnology
PrivateAcquisitionMajorityPrivate Equity
Syntimmune

target

Syntimmune

Alexion Pharmaceuticals

bidder

Alexion Pharmaceuticals

£1,073m

22 dealmakers

United States
Biotechnology
AcquisitionMajorityPublic
Achillion Pharmaceuticals

target

Achillion Pharmaceuticals

Alexion Pharmaceuticals

bidder

Alexion Pharmaceuticals

£732m

21 dealmakers

United States
Biotechnology
MajorityPublicAcquisitionTender Offer
Portola Pharmaceuticals

target

Portola Pharmaceuticals

Alexion Pharmaceuticals

bidder

Alexion Pharmaceuticals

£1,306m

50 dealmakers

United States
Biotechnology
MajorityPublicAcquisitionCross Border
Alexion Pharmaceuticals

target

Alexion Pharmaceuticals

Astrazeneca

bidder

Astrazeneca

£29,441m

63 dealmakers

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US